Fatal subcutaneous aspergillosis following necrotizing fasciitis: a case report. by Falsey, A. R. et al.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 63 (1990), 9-13
Fatal Subcutaneous Aspergillosis Following
Necrotizing Fasciitis: A Case Report
ANN R. FALSEY, M.D.,a R. DAVID GOLDSTICKER, M.D.,b
AND MARY JEAN AHERN, M.D.C
aFellow, Infectious Diseases, Yale University SchoolofMedicine, New Haven,
Connecticut;bResident, Pathology, Hospital ofSt. Raphael, New Haven,
Connecticut; cAssociate Director, Infectious Diseases, Hospital ofSt. Raphael,
and Associate Clinical Professor, Yale University School ofMedicine,
New Haven, Connecticut
Received July 14, 1989
Skin or subcutaneous infection with aspergillus is uncommon. It has been described in
disseminated aspergillosis, as localized infection in the immunocompromised host and as a
complication oftrauma and burns. Described in this paper is a diabetic patient who developed a
fatal Aspergillus infection following debridement of a necrotizing fasciitis. "Fruiting bodies,"
rarely found in vivo, were seen on pathologic examination ofsubcutaneous tissue. Her course was
similar to that of burn patients with invasive fungal disease, where mortality is high and radical
debridement is the only chance for cure.
Aspergillus is a ubiquitous, saprophytic mold which grows well in soil and on organic
debris [1]. Aspergillosis is a significant cause of morbidity and mortality in patients
with altered host defenses. Patients with hematologic malignancies and neutropenia
are the most commonly affected, but Aspergillus infection has also been described in
patients with collagen vascular disease, sarcoid, and organ transplants as well [1].
Invasive or disseminated aspergillosis is rare in the normal host [2,3]. Although
Aspergillus may invade almost any tissue, the lung, gastrointestinal tract, and the
central nervous system are the most frequent sites of infection [1,4]. Cutaneous
Aspergillus infection is uncommon. A recent review ofaspergillosis from the National
Cancer Institute noted that only two out of98 patients had skin involvement [2].
In this report we describe a diabetic patient who developed a rapidly progressive,
fatal Aspergillusfumigatus infection of a wound following debridement for necrotiz-
ing fasciitis. Fungal infections of wounds have been reported in trauma [5] and burn
victims [21-23], but to our knowledge aspergillosis has not been previously described
following a surgical debridement procedure.
CASE REPORT
A 60-year-old, insulin-dependent diabetic white female was admitted tothe Hospital
of St. Raphael with severe necrotizing fasciitis. Her past medical history was notable
for penicillin allergy and chronic renal failure, requiring hemodialysis. She had not
been previously maintained on peritoneal dialysis.
9
Address reprint requests to: Ann R. Falsey, M.D., DivisionofInfectious Diseases, UniversityofRochester
School ofMedicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642
Copyright © 1990 by The Yale Journal ofBiology and Medicine, Inc.
All rights ofreproduction in any form reserved.FALSEY ET AL.
FIG. 1. Anterior abdomi-
nal wall debridement site.
Necrotic areas showing ex-
tensive mycelial growth are
visible on the surface of the
subcutaneous tissue.
One week prior to admission, the patient developed a labial abscess and low-grade
fever. The abscess progressed rapidly to a necrotizing fasciitis, involving the anterior
abdominal wall, thigh, and perineum. On the day of admission she was febrile with a
toxic appearance. She was taken to the operating room for extensive debridement and
begun on vancomycin, gentamicin, and metronidazole. Cultures of debrided tissue
grew E. coli, S.faecalis, and microaerophilic streptococcus. Her post-operative course
was complicated by hypotension, adult respiratory distress syndrome, and dissemi-
nated intravascular coagulation.
Despite her initial difficult course, the patient stabilized, fever and leukocytosis
gradually resolved, and antibiotics were discontinued after 12 days. She was treated
with intensive local care and whirlpool therapy. The wound was packed with sterile
gauze. No elastic wraps or bandages were used. Despite this regimen, one week later
she again became hypotensive and febrile, and the wound appeared purulent. Cultures
grew Pseudomonas maltophilia, Klebsiella pneumoniae, and E. coli. Ceftazidime,
gentamicin, and metronidazole were begun with a good clinical response.
On the tenth day of her second course of antibiotics, dry, black areas of necrosis
appeared on the wound surface. Within 24 hours, a blue green mold was observed to
be growing in areas of necrosis (see Fig. 1). The patient was taken for her third
debridement. Operating room specimens showed fungal invasion of the subcutaneous
tissue and muscle (Figs. 2, 3). The cultures grew Aspergillus fumigatus. She was
begun on amphotericin B at a dose of 1.0 milligrams per kilogram per day following
debridement. Antibacterial agents were discontinued. Within 72 hours of surgery,
grossly obvious fungal growth recurred. Topical amphotericin B was added to systemic
treatment. A fourth debridement was attempted. Deep tissue necrosis was found, with
involvement of the small bowel. Pathology of the small bowel was not obtained. The
fungal infection was felt to be so extensive that resection was not possible. Comfort
measures were instituted, and dialysis and amphotericin were stopped. She had
received approximately 500 milligrams ofintravenous amphotericin B. She died on the
forty-first hospital day. Permission for autopsy was not granted.
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FIG. 2. Periodic Acid-
xmg.; ~~~~~~~Schiff stain of subcutaneous
tissuebiopsy. Dichotomously
branched, septate hyphae,
characteristic of Aspergil-
lus, can be seen invading
deep into tissuesection (orig-
inal magnification, 100x)
DISCUSSION
Cutaneous aspergillosis can be divided into three main categories: (1) skin lesions
associated with disseminated disease, (2) primary cutaneous aspergillosis, and (3)
aspergillus infection complicating burn wounds. Fungal infection associated with burn
wounds is most analogous to the patient in this case report.
Invasion of the dermis in disseminated aspergillosis is uncommon, occurring in less
than 5 percent of cases [6]. Lesions are multiple, suggesting embolic, hematogenous
spread, usually from a primary lung source [1,6]. The typical rash begins as erythema-
tous pustules which ulcerate and become necrotic. Aspergillusfumigatus has been the
most common isolate [1,6,7].
Primary cutaneous lesions may occur in normal hosts or in immunocompromised
patients. In normal hosts, infection typically follows minor trauma and follows an
indolent course, requiring only local therapy [8-12]. Elasticized bandages have been
associated with outbreaks offungal infections such as Mucor in surgical patients. The
bandages themselves have been found to be the source of fungal contamination [13].
Our patient was never exposed to tape, elastic bandages, or wraps. Her wound was
dressed with individually sterilized, pre-packaged gauze, which was widely used
throughout the hospital. While the gauze was not cultured, there were no other cases of
Aspergillus wound infections reported in the hospital during this period to suggest this
possibility as a source of contamination. The surfaces of the whirlpool tank were
cultured for fungal colonization and were found to be free ofAspergillus.
Localized primary Aspergillus infection in the immunocompromised host usually
occurs in clusters and has been related to trauma from intravenous catheters, arm-
boards, or tape. Aspergillus flavus is the most common isolate [7,14-18]. When
outbreaks of cutaneous aspergillosis occur, wound dressings and tape should be
cultured. Successful treatment requires theresolution ofneutropenia, systemic ampho-
tericin B therapy, catheter removal, and local wound care [17].
Fungal infection of traumatic wounds and burns has been described in the surgical
literature. While Candida frequently colonizes burns, true fungal invasion is most
commonly attributed to various species of Zygomycetes and Aspergillus [19-21].
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FIG. 3. Grocott's methe-
namine silver stain of biopsy
taken from tissue surface.
Note the numerous conidio-
phores (original magnifica-
a tion,400x).
Isolation ofAspergillus from a burn wound or devitalized tissue is rarely colonization
and often carries a grave prognosis [20]. In a study of 30 burn patients, indications of
fungal infection were: superficial necrosis, violaceous discoloration, or "black spots."
As with our patient, the surface appearance did not convey the extent ordepth oftissue
necrosis [22]. Biopsy frequently shows invasion of hyphae into deep tissue and
thrombosis of blood vessels with ischemia and gangrene. Extensive spread beneath
intact skin may be found [21]. "Fruiting bodies" or conidiophores ofAspergillus are
seen almost exclusively in culture media, and the presence offruiting bodies in vivo is
exceedingly rare. There has beenonlyonepriorcasereport of"fruiting bodies" isolated
from a patient, an individual with extensive burn wounds [23]. Hyphae invasion is
typically seen in tissues rather than conidiophores, which were seen in this patient.
The primary mode of therapy is wide surgical excision or amputation [18-22,24].
Topical or systemic antifungals were never individually successful in controlling the
infection. Recurrence afterdebridement wasvery common, occurring in 33-83 percent
of cases [22]. Stone et al. suggested that systemic amphotericin B and topical
antifungals were beneficial in adjunctive roles in preventing recurrent disease following
debridement. Even with optimal therapy, mortality is high, estimated to be between
30-78 percent [21,22,24].
Our patient is analogous to the burn patient with large areas ofdevitalized, exposed
tissue. She was also immunocompromised by virtue of her diabetes and chronic renal
failure. In this population, cutaneous aspergillus carries a grave prognosis. Unlike
other forms of cutaneous aspergillosis, systemic amphotericin is only adjunctive
therapy. The primary mode of treatment is debridement. In this type of patient,
Aspergillus isolated from the surface of the wound should not be considered a
contaminant or superficial colonization. Prompt evaluation of the depth of fungal
penetration and appropriate surgical intervention is imperative.
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